-+ 0.00%
-+ 0.00%
-+ 0.00%

HALOZYME THERAPEUTICS - ELIGIBLE FOR MILESTONE PAYMENTS AND ROYALTIES ON ENHANZE PRODUCT SALES

Reuters·10/06/2026 20:07:33